Effect of Low-Dose Mulberry Fruit Extract on Postprandial Glucose and Insulin Responses: A Randomized Pilot Trial in Individuals with Type 2 Diabetes
Nutrients · 2024
DOI: 10.3390/nu16142177 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von David J Mela und 4 weiteren Autor:innen. Beteiligte Einrichtung: Unilever Foods Innovation Centre Wageningen, 6708 WH Wageningen, The Netherlands. Hauptthemen laut MEDLINE: Blood Glucose, Diabetes Mellitus, Type 2, Fruit, Morus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Unilever (Netherlands).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Adding mulberry fruit extract (MFE) to carbohydrate-rich meals can reduce postprandial glucose (PPG) and insulin (PPI) responses in healthy individuals. This pilot study assessed the acute postprandial effects of low doses of MFE in individuals with type 2 diabetes. In a randomized cross-over (within-subjects) design, 24 unmedicated adult males and females with type 2 diabetes (mean [SD] age 51.0 [9.3] yr, BMI 27.5 [3.9] kg/m2) consumed meals with 0 (control), 0.37, and 0.75 g of MFE added to ~50 g of available carbohydrates from rice. Primary and secondary outcomes were the PPG 2 hr positive incremental area under the curve and the corresponding PPI. Results were reported as mean differences from the control meal with 95% CI. Relative to control, 0.37 and 0.75 g of MFE reduced the mean 2 hr PPG by 8.2% (−20.8 to 6.6%) and 22.4% (−38.6 to −1.9%), respectively, and reduced PPI by 9.6% (−20.7 to 3.0%) and 17.5% (−27.9 to −5.7%). There were no indications of adverse events or gastrointestinal discomfort. MFE additions also led to dose-related reductions in glucose peak and glucose swing. At these levels, MFE appears to dose-dependently reduce acute PPG and PPI in individuals with type 2 diabetes and may be a feasible dietary approach to help attenuate glycemic exposures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unilever Foods Innovation Centre Wageningen, 6708 WH Wageningen, The Netherlands.
- Unilever Industries Private Limited, Mumbai 400099, India.
ORCID-Profile: David J Mela
Förderung
- Unilever (Netherlands)
Zitieren
APA
Mela, D. J., Alssema, M., Hiemstra, H., Hoogenraad, A. R., & Kadam, T. (2024). Effect of Low-Dose Mulberry Fruit Extract on Postprandial Glucose and Insulin Responses: A Randomized Pilot Trial in Individuals with Type 2 Diabetes. Nutrients. https://doi.org/10.3390/nu16142177
Vancouver
Mela DJ, Alssema M, Hiemstra H, Hoogenraad AR, Kadam T. Effect of Low-Dose Mulberry Fruit Extract on Postprandial Glucose and Insulin Responses: A Randomized Pilot Trial in Individuals with Type 2 Diabetes. Nutrients. 2024. doi:10.3390/nu16142177
BibTeX
@article{Mela2024,
author = {Mela, David J and Alssema, Marjan and Hiemstra, Harry and Hoogenraad, Anne-Roos and Kadam, Tanvi},
title = {Effect of Low-Dose Mulberry Fruit Extract on Postprandial Glucose and Insulin Responses: A Randomized Pilot Trial in Individuals with Type 2 Diabetes},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16142177}
}
EUVIMED